The CyberKnife® Robotic Radiosurgery System has been FDA-cleared for more than 10 years. The first prostate cancer patient was treated in 2002 and since then thousands of prostate cancer patients worldwide have been treated with the CyberKnife System. A total of 14 peer-reviewed studies involving more than 700 patients have been published showing the efficacy of non-invasive CyberKnife prostate SBRT (stereotactic body radiation therapy) in terms of disease-free survival, toxicity, and preservation of sexual function. Accuray advises that patients discuss with their physicians their treatment options in order to determine which one is best for their individual case.

Enrolling Prostate Patients

The PACE Study: A randomized study comparing surgery, CyberKnife and conventional radiation therapy for early stage prostate.

Click here to visit the website.

Or email someone with Accuray here.

PACE Study Fact Sheet

Find even more information about the PACE study

Benefits of CyberKnife Prostate SBRT

Clinical Information

5-Year Outcomes

Published 5-year outcomes for CyberKnife prostate SBRT

SBRT vs. IMRT, Proton Radiation Therapy

Cost-effectiveness of SBRT versus IMRT and proton radiation therapy for localized prostate cancer

CyberKnife Compared to da Vinci Surgery for Prostate Treatment

Overview of CyberKnife prostate SBRT vs da Vinci surgery

Prostate SBRT Webinar

Addressing patient selection and comparisons with other radiation treatments for prostate cancer

Prostate Bibliography

Published clinical and technical CyberKnife articles

CyberKnife System

CyberKnife System

Overview of the CyberKnife VSI System

CyberKnife Prostate Solutions

Overview of CyberKnife prostate solutions

CyberKnife for Prostate

Overview of CyberKnife prostate treatments

InTempo

Solution to manage prostate motion

AERO

AERO Website

Accuray Exchange in Radiation Oncology (AERO)

Reimbursement

Medicare Map

U.S. Coverage of the CyberKnife System

Ongoing Research

Registry for Prostate Cancer Radiosurgery

The Registry for Prostate Cancer Radiosurgery (RCPR) is a multi-institutional IRB approved prospective observational trial. The goals of the registry include improved quality of care and improved patient access to Stereotactic Body Radiation Therapy (SBRT) for prostate cancer patients. RPCR is a nationwide trial that tracks prostate cancer patient demographics, treatment specifics, outcomes, and payor information.

 Visit the RPCR Registry

Enrolling Prostate Patients

The PACE Study: A randomized study comparing surgery, CyberKnife and conventional radiation therapy for early stage prostate.

Click here to visit the website.

Patient Brochure

CyberKnife information for patients

Information Sheet

CyberKnife prostate information guide

CyberKnife Podcast

Listen to physicians discussing benefits of CyberKnife treatment

Resources for Your Doctor

A list of prostate related clinical and technical resources

Warren’s Cancer Chronicle: The Story of a CyberKnife Patient

Visit the CyberKnife Patient Website

Click here to visit our patient website and learn more about the CyberKnife System.

  • What is CyberKnife?
  • What Can CyberKnife Treat?
  • Patient Stories